Chronix Biomedical Company

Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients. Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status.
Chronix plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany.
Technology: MarketPlace
Industry: P4 Medicine
Headquarters: United States
Founded Date: 1997
Employees Number: 1-10
Funding Status: undisclosed
Investors Number: 3
Total Funding: $21.5M
Estimated Revenue: $10M to $50M
Last Funding Type: Venture - Series Unknown

Visit Website
info@chronixbiomedical.com
https://www.twitter.com/chronixbio
Register and Claim Ownership